Larvol Delta - Aclaris-Therapeutics-Initiates-Phase-1b-ProofofConcept-Trial-in-Atopic-Dermatitis-AD-with-Its-Novel-Bispecic-Antibody-ATI052

ATI-052 - Aclaris

https://www.globenewswire.com/news-release/2026/01/12/3216681/37216/en/Aclaris-Therapeutics-Initiates-Phase-1b-Proof-of-Concept-Trial-in-Atopic-Dermatitis-AD-with-Its-Novel-Bispecific-Antibody-ATI-052.html

Jan 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next